The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Forestier, C.
Right arrow Articles by Porcelli, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Forestier, C.
Right arrow Articles by Porcelli, S. A.
The Journal of Immunology, 2005, 175: 763-770.
Copyright © 2005 by The American Association of Immunologists

Expansion and Hyperactivity of CD1d-Restricted NKT Cells during the Progression of Systemic Lupus Erythematosus in (New Zealand Black x New Zealand White)F1 Mice1

Claire Forestier*, Alberto Molano*, Jin Seon Im*, Yves Dutronc{dagger}, Betty Diamond{ddagger}, Anne Davidson{ddagger}, Petr A. Illarionov§, Gurdyal S. Besra§ and Steven A. Porcelli2,*

* Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461; {dagger} Department of Dermatology, Bocage Hospital, Dijon, France; {ddagger} Department of Medicine, Columbia University, NY 10032; and § School of Biosciences, University of Birmingham, Edgbaston, United Kingdom

CD1d-restricted NKT cells expressing invariant TCR {alpha}-chain rearrangements (iNKT cells) have been reported to be deficient in humans with a variety of autoimmune syndromes and in certain strains of autoimmune mice. In addition, injection of mice with {alpha}-galactosylceramide, a specific glycolipid agonist of iNKT cells, activates these T cells and ameliorates autoimmunity in several different disease models. Thus, deficiency and reduced function in iNKT cells are considered to be risk factors for the development of such diseases. In this study we report that the development of systemic lupus erythematosus in (New Zealand Black (NZB) x New Zealand White (NZW))F1 mice was paradoxically associated with an expansion and activation of iNKT cells. Although young (NZB x NZW)F1 mice had normal levels of iNKT cells, these expanded with age and became phenotypically and functionally hyperactive. Activation of iNKT cells in (NZB x NZW)F1 mice in vivo or in vitro with {alpha}-galactosylceramide indicated that the immunoregulatory role of iNKT cells varied over time, revealing a marked increase in their potential to contribute to production of IFN-{gamma} with advancing age and disease progression. This evolution of iNKT cell function during the progression of autoimmunity may have important implications for the mechanism of disease in this model of systemic lupus erythematosus and for the development of therapies using iNKT cell agonists.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. M. Venkataswamy, A. Baena, M. F. Goldberg, G. Bricard, J. S. Im, J. Chan, F. Reddington, G. S. Besra, W. R. Jacobs Jr., and S. A. Porcelli
Incorporation of NKT Cell-Activating Glycolipids Enhances Immunogenicity and Vaccine Efficacy of Mycobacterium bovis Bacillus Calmette-Guerin
J. Immunol., August 1, 2009; 183(3): 1644 - 1656.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. To, A. Agrotis, G. Besra, A. Bobik, and B.-H. Toh
NKT Cell Subsets Mediate Differential Proatherogenic Effects in ApoE-/- Mice
Arterioscler Thromb Vasc Biol, May 1, 2009; 29(5): 671 - 677.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Wang, S. Cho, A. Ueno, L. Cheng, B.-Y. Xu, M. D. Desrosiers, Y. Shi, and Y. Yang
Ligand-Dependent Induction of Noninflammatory Dendritic Cells by Anergic Invariant NKT Cells Minimizes Autoimmune Inflammation
J. Immunol., August 15, 2008; 181(4): 2438 - 2445.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Tsukamoto, M. Ohtsuji, W. Shiroiwa, Q. Lin, K. Nakamura, H. Tsurui, Y. Jiang, K. Sudo, H. Nishimura, T. Shirai, et al.
Aberrant Genetic Control of Invariant TCR-Bearing NKT Cell Function in New Zealand Mouse Strains: Possible Involvement in Systemic Lupus Erythematosus Pathogenesis
J. Immunol., April 1, 2008; 180(7): 4530 - 4539.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Loh, Y.-C. Cai, G. Bonventi, G. Lajoie, R. MacLeod, and J. E. Wither
Dissociation of the Genetic Loci Leading to B1a and NKT Cell Expansions from Autoantibody Production and Renal Disease in B6 Mice with an Introgressed New Zealand Black Chromosome 4 Interval
J. Immunol., February 1, 2007; 178(3): 1608 - 1617.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.